Modulation of Axon Degeneration
AssigneeGenentech, Inc.
InventorsRyan Watts, Mark Chen, Joseph Wesley Lewcock, Christine Pozniak, Arundhati Sengupta-Ghosh
Life of this patent
Estimating the term…
Abstract
The invention relates generally to treatment of neurological disorders and nervous system injuries. The invention specifically provides methods of using modulators of particular target proteins to modulate degeneration of neurons or portions thereof, such as axons.
Claims31
A method for inhibiting degeneration of a neuron or a portion thereof, the method comprising administering to the neuron or portion thereof an agent that modulates:
- (i) the activity or expression of a target protein in the neuron or portion thereof, or (ii) a process in the neuron or portion thereof.
A method of identifying an agent for use in inhibiting degeneration of a neuron or portion thereof, the method comprising contacting a neuron or portion thereof with a candidate agent in an assay of axon or neuron degeneration, wherein detection of reduced degeneration of the neuron or portion thereof in the presence of the candidate agent, relative to a control, indicates the identification of an agent for use in inhibiting degeneration of a neuron or portion thereof.
A pharmaceutical composition or kit comprising one or more agent that can be used to inhibit degeneration of a neuron or portion thereof.
A method for activating degeneration of a neuron or a portion thereof, the method comprising administering to a neuron or portion thereof an agent that modulates:
- (i) the activity or expression of a target protein in the neuron or portion thereof, or (ii) a process in the neuron or portion thereof.
Dependencies are inferred from the claim text.